These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21076360)

  • 1. Cost-effectiveness of glaucoma interventions in Barbados and Ghana.
    Wittenborn JS; Rein DB
    Optom Vis Sci; 2011 Jan; 88(1):155-63. PubMed ID: 21076360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of community screening for glaucoma in rural India: a decision analytical model.
    John D; Parikh R
    Public Health; 2018 Feb; 155():142-151. PubMed ID: 29407529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of family caregiving for elderly population in southern Ghana: the case of a peri-urban district.
    Nortey ST; Aryeetey GC; Aikins M; Amendah D; Nonvignon J
    Int J Equity Health; 2017 Jan; 16(1):16. PubMed ID: 28088236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
    Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Male circumcision at different ages in Rwanda: a cost-effectiveness study.
    Binagwaho A; Pegurri E; Muita J; Bertozzi S
    PLoS Med; 2010 Jan; 7(1):e1000211. PubMed ID: 20098721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness and cost utility of community screening for glaucoma in urban India.
    John D; Parikh R
    Public Health; 2017 Jul; 148():37-48. PubMed ID: 28404532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in England.
    Boodhna T; Crabb DP
    BMC Health Serv Res; 2016 Oct; 16(1):611. PubMed ID: 27770792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic cost of management of glaucoma in public and private health facilities in the Tema metropolis in Ghana.
    Adda M; Amon S; Nonvignon J; Aikins M; Aryeetey GC
    Ghana Med J; 2024 Mar; 58(1):17-25. PubMed ID: 38957274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic impact of primary open-angle glaucoma in Australia.
    Dirani M; Crowston JG; Taylor PS; Moore PT; Rogers S; Pezzullo ML; Keeffe JE; Taylor HR
    Clin Exp Ophthalmol; 2011; 39(7):623-32. PubMed ID: 21631669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [On the socio-economic relevance of glaucoma].
    Grüb M; Rohrbach JM
    Klin Monbl Augenheilkd; 2006 Oct; 223(10):793-5. PubMed ID: 17063419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Barbados Eye Study. Prevalence of open angle glaucoma.
    Leske MC; Connell AM; Schachat AP; Hyman L
    Arch Ophthalmol; 1994 Jun; 112(6):821-9. PubMed ID: 8002842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies.
    Leech AA; Kim DD; Cohen JT; Neumann PJ
    Value Health; 2018 Jul; 21(7):759-761. PubMed ID: 30005746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care cost and benefits of artificial intelligence-assisted population-based glaucoma screening for the elderly in remote areas of China: a cost-offset analysis.
    Xiao X; Xue L; Ye L; Li H; He Y
    BMC Public Health; 2021 Jun; 21(1):1065. PubMed ID: 34088286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of visual loss and their risk factors: an incidence summary from the Barbados Eye Studies.
    Leske MC; Wu SY; Nemesure B; Hennis A;
    Rev Panam Salud Publica; 2010 Apr; 27(4):259-67. PubMed ID: 20512228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic implications of glaucoma: a literature review.
    Schmier JK; Halpern MT; Jones ML
    Pharmacoeconomics; 2007; 25(4):287-308. PubMed ID: 17402803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
    van Hulst M; Sagoe KW; Vermande JE; van der Schaaf IP; van der Tuuk Adriani WP; Torpey K; Ansah J; Mingle JA; Smit Sibinga CT; Postma MJ
    Value Health; 2008; 11(5):809-19. PubMed ID: 18489518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The magnitude and cost of global blindness: an increasing problem that can be alleviated.
    Frick KD; Foster A
    Am J Ophthalmol; 2003 Apr; 135(4):471-6. PubMed ID: 12654362
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.